23 May 2013
Keywords: pfizer, warning, bextra, adds, concerns, over, cox-2
Article | 25 October 2004
US drug major Pfizer says that one of its best-selling painkillers, Bextra (valdecoxib), may increase the risk of cardiovascular events ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 October 2004
© 2013 thepharmaletter.com